REBIF RebiDose départ 6x8.8mcg + 6x22mcg 12 pce

7680620670017 CH-62067 L03AB07 01.99.0.
REBIF RebiDose départ 6x8.8mcg + 6x22mcg 12 pce
REBIF RebiDose départ 6x8.8mcg + 6x22mcg 12 pce
REBIF RebiDose départ 6x8.8mcg + 6x22mcg 12 pce
1 / 3
google

Details

Product number
6206701
CPT
-
Packaging group
6 + 6
Unit
Injektor(en), vorgefüllt/Pen
Composition
I) 8.8 mcg/0.2 ml: interferonum beta-1a ADNr 8.8 µg corresp. 2.4 Mio U.I., alcohol benzylicus 1.0 mg, mannitolum, methioninum, poloxamerum 188, natrii acetas trihydricus, natrii hydroxidum, acidum aceticum, aqua ad iniectabile q.s. ad solutionem pro 0.2 ml corresp. natrium 0.01 mg. II) 22 mcg / 0.5 ml: interferonum beta-1a ADNr 22 µg corresp. 6 Mio U.I., alcohol benzylicus 2.5 mg, mannitolum, methioninum, poloxamerum 188, natrii acetas trihydricus, natrii hydroxidum, acidum aceticum, aqua ad iniectabile q.s. ad solutionem pro 0.5 ml corresp. natrium max. 0.03 mg.

Articles (1)

Rebif 8.8 und 22 RebiDose, Injektionslösung im Fertigpen
Injektionslösung im Fertigpen
6 + 6
View

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Patient information leaflet
Allemand
23/05/2024
Patient information leaflet
Français
23/05/2024
Patient information leaflet
Italien
23/05/2024

Detailed composition

Substance Quantity Type Category
I
8.8 UG Substance Wirkstoff (Principe actif)
II
22.0 UG Substance Wirkstoff (Principe actif)
II
2.5 MG Substance HBESI
I
1.0 MG Substance HBESI
II
- Substance HNIDK
I
- Substance HNIDK
II
- Substance ANTOX
I
- Substance ANTOX
II
- Substance HNIDK
I
- Substance HNIDK
II
- Substance HNIDK
I
- Substance HNIDK
I
- Substance HNIDK
II
- Substance HNIDK
II
- Substance HNIDK
I
- Substance HNIDK
I
- Substance GALEN
II
- Substance GALEN
II
- Substance HBESI
I
0.01 MG Substance HBESI

Reimbursement information

Public price
CHF 668.35
Specialties list
Yes
Generic
No
SL addition date: 01/10/2013

Authorization holder

Merck (Schweiz) AG

6300 Zug

Authorization information

Swissmedic authorization number
62067
Drug name
Rebif RebiDose, Injektionslösung im Fertigpen
Galenic form
LSPA
ATC Code
L03AB07
Authorization status
Z
Dispensation category
B
First authorization
13/02/2012
Authorization expiration date
31/12/9999
IT number
01.99.0.
Domain
Human medicine
Field of application
Multiple Sklerose

Packaging details

Description (FR)
REBIF RebiDose départ 6x8.8mcg + 6x22mcg 12 pce
Description (DE)
REBIF RebiDose Startpack 6x8.8mcg + 6x22mcg 12 Stk
Market launch
13/02/2012
Narcotic (BTM)
No

Other packaging sizes

REBIF 22 RebiDose 22 mcg/0.5 ml stylo pré 12 pce
12 INJ
View
REBIF 44 RebiDose 44 mcg/0.5 ml stylo pré 12 pce
12 INJ
View